VILNIUS, Lithuania, Nov. 12, 2025 — Global health and wellness company Kilo Health rebrands to Kilo. The move reflects its expansion into new business opportunities in longevity, anti-ageing, beauty, and personal development. It also demonstrates Kilo’s growing focus on co-founding, venture building and early-stage startup investments.
Founded in 2013, Kilo Health has grown from a local wellness startup into a global healthtech force, building a wide range of solutions – from digital apps to physical products – that have reached over 10 million consumers worldwide.
In 2022, Kilo Health was named Europe’s second fastest-growing tech company by the Financial Times. Now, the company is bringing its expertise in building and scaling ventures to other founders. Kilo’s current portfolio includes nine strong ventures, including Bioma, Pulsetto, Go Health, Ratepunk, and others.
Rebranding to Kilo marks the company’s evolution into a highly valued co-founding partner for entrepreneurs building new, exciting businesses in health, wellness, beauty and personal development.
“Kilo has expanded from one product to over 30. Now, it’s time to share that experience with the next generation of builders,” says Žygimantas Surintas, CEO of Kilo. “Our goal is to empower entrepreneurs with both funding and the operational power to move fast and make an impact.”
A Partner for High-Velocity Growth
Kilo provides ambitious entrepreneurs with hands-on support from the MVP stage, enabling them to build, test and scale innovative ideas together at exceptional speed. The company will partner with builders primarily in health and wellness, while also exploring other high-potential industries.
Kilo’s initial investment tickets range from €50,000 to €1 million, with follow-on funding reaching up to €10 million. To date, the company has invested over €10 million in external startups and nearly twice that amount in its own R&D and product development.
These efforts are powered by Kiloverse – Kilo’s internal ecosystem, which provides the infrastructure and knowledge: access to marketing expertise, technology tools, and global partnerships; experience in direct-to-consumer product business models and experts in R&D, nutrition, research, and others.
Kilo Health, now – Kilo, has demonstrated exceptional business growth, doubling its revenues over the past five years to surpass €233 million this year. In the next three years, Kilo plans to invest an additional €20 million in AI development and reach almost €9 billion in revenue.
Headquartered in Vilnius, Lithuania, Kilo employs over 500 people globally.
By connecting directly to a business inbox, EVE turns everyday communications into a real-time revenue engine – automating what traditional CRMs never could
SAN FRANCISCO, Nov. 11, 2025 — EVE, the first Inbox Revenue Engine for B2B small businesses, today announced it has raised $2 million in pre-seed funding led by Firsthand.VC, with participation from a16z’s Scout Fund, Acquisition.com Ventures, Geek Ventures, Founders Future, Punch Capital, Silicon Gardens and prominent angels, including co-founders of Slack and Hugging Face, and the former CEO of Oura. The funding will accelerate product development and support EVE’s rollout to hundreds of small businesses already on its waitlist – a first step toward scaling to thousands in the coming months.
EVE acts as an always-on Inbox Revenue Engine, connecting directly to email and calendar to track and manage real-time revenue activity – automatically identifying new opportunities, surfacing forgotten leads, and drafting context-aware follow-ups. By eliminating the need for manual CRM updates or workflow changes, EVE helps small businesses recover 20–30% of potential revenue lost in day-to-day communication gaps.
“CRMs were built for people who have time for managing them. Small businesses don’t have time for all of this, starting with manual data entry,” said Vadim Rogovskiy, CEO and co-founder of EVE. “EVE lives inside email and calendar and does the work for you autonomously, turning everyday conversations into a single live revenue machine where nothing gets lost.”
“Building on the idea of revenue intelligence, EVE adds autonomous execution and visibility. It doesn’t just tell teams what to do; it helps them do it – learning from every connected inbox to build a single live dashboard of all revenue activity across the company – making it easy to see what’s moving, what’s stalled, and what’s being missed.”
While in stealth, over 500 small businesses joined EVE’s waitlist, with some of them already turning their inboxes into live revenue dashboards.
“I didn’t realize how much revenue was buried in our inbox until EVE started identifying it and helping us to close it,” said Josh Hess, VP of Business Development at Leadature, one of EVE’s first customers. “In just three months, we closed 25% more deals with the same team and no workflow changes.”
The idea for EVE emerged after hundreds of interviews with SMB owners, revealing that up to 80% of their work happens over email –yet most of that intelligence never makes it into CRMs or project management tools. Before founding EVE, Rogovskiy was building an AI-driven roll-up of small businesses, acquiring and modernizing operations with AI agents. “That journey exposed how much value was being lost inside inboxes,” said Rogovskiy. “EVE is the AI Inbox Revenue Engine designed to fix that.”
“I back people first, and Vadim has shown exceptional clarity in navigating this market,” said Simon Chan, General Partner at Firsthand.VC, and a four-time founder whose own company was acquired by Salesforce. “Having helped build Salesforce’s Einstein platform, I can say EVE is reimagining CRM from the ground up – bringing automation and intelligence to the businesses that need it most.”
EVE is built for industries where email volume directly equals revenue potential – including consulting, construction, distribution, recruiting, brokerage, and event management. The platform integrates seamlessly with Gmail and Outlook, requires no setup or training, and starts delivering insights within minutes. Future releases will expand into multi-channel lead tracking, upsell detection, and churn prediction, bringing small businesses a step closer to a fully autonomous revenue engine
About EVE
EVE is the first Inbox Revenue Engine for small businesses. By integrating with email, documents, and calendars, EVE continuously identifies overlooked leads, stalled deals, and buying signals – helping companies unlock 20–30% of hidden revenue without changing how they work. Co-founded by Vadim Rogovskiy, serial entrepreneur and founding partner at Rebel Capital, EVE is building the default revenue operating system for the next generation of SMBs.
MINNEAPOLIS, Nov. 11, 2025 — iRiva Medical, Inc., a privately held, development stage medical device company based in Minneapolis, and NuXcel spinoff, announced the closing of its initial financing led by F-Prime, with participation from Hatteras Venture Partners, Norwest, and Treo Ventures The proceeds of this financing will provide resources to enable the company to pursue the development and commercialization of innovative neuromodulation technology platforms to treat large patient populations suffering from chronic diseases.
Concurrent with financing, the company announced the hiring of Steve Masson as President and Chief Executive Officer. Mr. Masson is an experienced senior executive with more than 40 years in the medical device business, including 35 years in active implantable devices. Previously, Steve held senior executive and management roles for more than 30 years. He has served in general management, research and development, and operational positions in both venture capital-backed startups and large, revenue-driven companies, including Cordis, Ventritex, InnerPulse, NeuroTronik and Avivomed.
“We look forward to partnering with our seasoned investor group and benefitting from their depth of experience in medtech and neuromodulation. I am excited and appreciative to join the iRiva team as we work together to deliver a new and innovative therapy to patients and clinicians,” Mr. Masson commented.
iRiva is the fourth company to be launched out of NuXcel, a medical device accelerator managed by Mudit Jain and Lynn Elliott, with backing by Treo Ventures. “We are excited to have Steve Masson joining another NuXcel spinoff, honored to have the support of world-class investors and looking forward to partnering with this experienced syndicate to deliver on iRiva Medical’s mission,” said NuXcel founder and CTO, Lynn Elliott.
“We are thrilled to partner once again with Steve Masson, the NuXcel team, and this investor syndicate and look forward to realizing iRiva’s mission of delivering state-of-the-art neuromodulation therapy to patients with significant unmet clinical need,” said Kevin Chu, Principal at F-Prime.
Forge Global’s $660 million acquisition and Animoca Brands’ planned Nasdaq listing mark defining moments for the True Global Ventures Funds 4 and 5.
SINGAPORE, Nov. 11, 2025 — True Global Ventures (TGV), the global venture capital firm investing in AI and Blockchain technology companies celebrates a historic week in the U.S.
Two of TGV’s flagship investments — Forge Global Holdings (NYSE: FRGE) and Animoca Brands Corporation Limited — have each achieved transformative milestones that highlight the fund’s long term commitment to backing visionary entrepreneurs shaping the future of finance and digital assets.
Forge Global’s $660 million acquisition and Animoca Brands’ planned Nasdaq listing mark defining moments for the True Global Ventures Funds 4 and 5.
FORGE GLOBAL ACQUIRED BY CHARLES SCHWAB FOR $660 MILLION
Charles Schwab Corporation has agreed to acquire Forge Global for approximately US $660 million, valuing the company at about US $45 per share.
Forge Global has pioneered digital infrastructure that enables liquidity in private equity and venture capital, connecting investors, shareholders, and private companies in one of the world’s largest and fastest-growing secondaries ecosystems.
“Moments like this remind us why we invest for the long run,” said Dušan Stojanović, original founder of True Global Ventures, a visionary supporting extraordinary entrepreneurs. “Forge Global has redefined how liquidity is created and managed in private markets. Its acquisition by Charles Schwab reflects the accelerating convergence between traditional finance and the private-markets economy — a space where TGV has invested since inception. We believe that Forge Global will continue to innovate in areas like tokenisation of private company stock and funds!“
Kelly Rodrigues, CEO of Forge Global, added: “This partnership with Charles Schwab represents an inflection point for private markets. Forge was built to democratize access to private-company investments, and joining forces with one of the world’s most trusted financial institutions will dramatically accelerate that mission. We’re proud to have had long-term partners like TGV who believed in this vision from the start.”
ANIMOCA BRANDS PURSUING NASDAQ LISTING VIA CURRENC GROUP INC.
Animoca Brands has proposed a merger with Currenc Group Inc. (Nasdaq: CURR) through which Animoca’s shareholders would own approximately 95% of the combined entity. The merger is expected to complete in H2 2026 and result in a Nasdaq-listed company.
Animoca Brands is building the foundational layer of digital property rights. Its partnership with Currenc creates powerful potential synergies across cross-border payments, stablecoins, and tokenized digital assets — combining Web3 innovation with next-generation financial infrastructure.
Yat Siu, Co-Founder and Executive Chairman of Animoca Brands, commented: “A Nasdaq listing via Currenc represents a major step toward mainstream adoption of digital assets and tokenization. It enables us to bring the benefits of digital property rights — from gaming and education to finance and beyond — to an even broader audience.”
He continued: “Our collaboration with Currenc reflects shared DNA — both organizations are reinventing how value moves globally. Together, we aim to accelerate the transition toward open, interoperable digital economies. True Global Ventures has been a steadfast believer in this vision from the very beginning.”
Dušan Stojanović, commented: “Yat Siu is one of the most visionary entrepreneurs of our time. His leadership at Animoca Brands continues to shape the future of digital property rights. Our partnership spans over a decade, and seeing Animoca prepare for a Nasdaq listing is not only a testament to his vision, but to the power of persistence, innovation, and global collaboration. We are proud to have believed in this mission from its earliest stages.”
A DEFINING WEEK FOR TRUE GLOBAL VENTURES
These two milestones — one in private-markets liquidity, the other in digital-asset infrastructure — epitomize TGV’s investment philosophy: back visionary founders, accelerate scale in US and globally, bridge traditional finance with AI and Blockchain innovation.
A few months after being granted as a License Fund Management Company (LFMC) with a Capital Markets Services (CMS) license by the Monetary Authority of Singapore (MAS), True Global Ventures is now celebrating two major successes in the U.S, positioning itself among the best-performing venture capital funds globally.
ABOUT TRUE GLOBAL VENTURES True Global Ventures (TGV) is a global venture capital firm investing in AI and Blockchain technology companies at the growth and late stages. TGV’s portfolio includes Animoca Brands, Forge Global, Ledger, The Sandbox, Prezent, Coding Giants, Obligo, COVU, Validation Cloud, SATO, Chromaway, Jus Mundi, BookitnGo, GCEX, Coinhouse…and many others. Almost all portfolio companies in the U.S. or entering the U.S. With presence across San Francisco, New York, Paris, London, Stockholm, Dubai, Singapore and Hong Kong, TGV backs visionary founders building the next generation of transformative technology ventures.
L’acquisition de Forge Global pour 660 millions de dollars et le projet d’introduction d’Animoca Brands au Nasdaq marquent des jalons déterminants pour les fonds True Global Ventures 4 et 5.
SINGAPOUR, 11 novembre 2025 — True Global Ventures (TGV), société internationale de capital-risque investissant dans les entreprises de technologies d’intelligence artificielle (IA) et de blockchain, célèbre une semaine historique aux États-Unis.
Deux des investissements phares de TGV — Forge Global Holdings (NYSE : FRGE) et Animoca Brands Corporation Limited — ont chacun franchi des étapes majeures qui soulignent l’engagement à long terme du fonds à soutenir des entrepreneurs visionnaires façonnant l’avenir de la finance et des actifs numériques.
Forge Global’s $660 million acquisition and Animoca Brands’ planned Nasdaq listing mark defining moments for the True Global Ventures Funds 4 and 5.
FORGE GLOBAL ACQUISE PAR CHARLES SCHWAB POUR 660 MILLIONS DE DOLLARS
Charles Schwab Corporation a accepté d’acquérir Forge Global pour environ 660 millions de dollars américains, valorisant l’entreprise à environ 45 dollars par action.
Forge Global a été un pionnier dans le développement d’une infrastructure numérique facilitant la liquidité sur les marchés privés et reliant investisseurs, actionnaires et entreprises privées au sein de l’un des plus grands écosystèmes mondiaux de marchés secondaires, en forte croissance.
« Des moments comme celui-ci nous rappellent pourquoi nous investissons sur le long terme, » a déclaré Dušan Stojanović, fondateur initial de True Global Ventures et visionnaire soutenant des entrepreneurs d’exception. « Forge Global a redéfini la manière dont la liquidité est créée et gérée sur les marchés privés. Son acquisition par Charles Schwab reflète la convergence accélérée entre la finance traditionnelle et l’économie des marchés privés — un domaine dans lequel TGV investit depuis sa création. Nous croyons que Forge Global continuera d’innover dans des domaines tels que la tokenisation des actions et des fonds d’entreprises privées !»
Kelly Rodrigues, CEO de Forge Global, a ajouté : « Ce partenariat avec Charles Schwab représente un tournant pour les marchés privés. Forge a été créée pour démocratiser l’accès aux investissements dans les entreprises privées, et le fait de rejoindre l’une des institutions financières les plus fiables au monde va accélérer considérablement cette mission. Nous sommes fiers d’avoir eu des partenaires de long terme comme TGV, qui ont cru en cette vision dès le départ. »
ANIMOCA BRANDS ENVISAGE UNE COTATION AU NASDAQ VIA CURRENC GROUP INC.
Animoca Brands a proposé une fusion avec Currenc Group Inc. (Nasdaq : CURR), dans le cadre de laquelle les actionnaires d’Animoca détiendraient environ 95 % de la nouvelle entité combinée. La fusion devrait être finalisée au second semestre 2026, conduisant à une société cotée au Nasdaq.
Animoca Brands construit la couche fondamentale des droits de propriété numérique. Son partenariat avec Currenc crée des synergies puissantes dans les domaines des paiements transfrontaliers, des stablecoins et des actifs numériques tokenisés, combinant l’innovation Web3 et une infrastructure financière de nouvelle génération.
Yat Siu, cofondateur et président exécutif d’Animoca Brands, a déclaré : « Une cotation au Nasdaq via Currenc représente une étape majeure vers l’adoption massive des actifs numériques et de la tokenisation. Elle nous permettra d’apporter les avantages des droits de propriété numérique — du jeu vidéo et de l’éducation à la finance et au-delà— à un public encore plus large. »
Il poursuit : « Notre collaboration avec Currenc reflète un ADN commun — deux organisations qui réinventent la manière dont la valeur circule à l’échelle mondiale. Ensemble, nous voulons accélérer la transition vers des économies numériques ouvertes et interopérables. True Global Ventures a cru en cette vision depuis le tout début. »
Dušan Stojanović a ajouté : « Yat Siu est l’un des entrepreneurs les plus visionnaires de notre époque. Son leadership chez Animoca Brands continue de façonner l’avenir des droits de propriété numérique. Notre partenariat s’étend sur plus d’une décennie, et voir Animoca se préparer à une cotation au Nasdaq est non seulement un hommage à sa vision, mais aussi au pouvoir de la persévérance, de l’innovation, et de la collaboration mondiale. Nous sommes fiers d’avoir cru en cette mission dès ses débuts. »
UNE SEMAINE DÉTERMINANTE POUR TRUE GLOBAL VENTURES
Ces deux étapes — l’une dans la liquidité des marchés privés, l’autre dans l’infrastructure des actifs numériques — incarnent la philosophie d’investissement de TGV : soutenir des fondateurs visionnaires, accélérer la croissance à l’échelle mondiale et relier la finance traditionnelle à l’innovation en IA et Blockchain.
Quelques mois seulement après l’obtention de sa licence de société de gestion de fonds (LFMC) à travers une licence de services de marchés de capitaux (CMS) délivrée par l’Autorité Monétaire de Singapour (MAS), True Global Ventures célèbre aujourd’hui deux succès majeurs aux États-Unis, confirmant sa position parmi les meilleurs fonds de capital-risque au monde.
À PROPOS DE TRUE GLOBAL VENTURES True Global Ventures (TGV) est une société internationale de capital-risque investissant dans des entreprises de technologies d’intelligence artificielle et de blockchain aux stades de croissance et de maturité. Son portefeuille comprend notamment Animoca Brands, Forge Global, Ledger, The Sandbox, Prezent, Coding Giants, Obligo, COVU, Validation Cloud, SATO, Chromaway, Jus Mundi, BookitnGo, GCEX, Coinhouse, et bien d’autres. La plupart de ses entreprises sont implantées aux États-Unis ou y développent leurs activités. Présente à San Francisco, New York, Paris, Londres, Stockholm, Dubai, Singapore and Hong Kong, TGV soutient des fondateurs visionnaires qui construisent la prochaine génération de ventures technologies à fort impact.
NEW YORK, Nov. 11, 2025 — As much of the infrastructure sector turns its attention to artificial intelligence for design, engineering, and project planning, Dynamic Infrastructure continues to define the next frontier: Operational and Maintenance AI, empowering public agencies and private owners to maximize every dollar where most budgets are ultimately spent and efficiency matters most.
Saar Dickman, CEO
Building on more than three years of successful AI deployment supporting bridge, culvert, and roadway owners worldwide, the company today announced the release of the next version of its Virtual Assistant Engineer, now rolling out to flagship users before general availability later this month.
“Most of the industry discussion today revolves around using AI for design and construction planning,” said Saar Dickman, CEO of Dynamic Infrastructure. “We respect that progress, but our mission has always been to help counties, cities, and state agencies operate more effectively, safely, and efficiently in the real world, where budgets are tight and every maintenance action counts.”
The new version of the Virtual Assistant Engineer introduces enhanced automation in inspection review and evaluation, turning inspection data into planned action, cross-asset risk forecasting, and FEMA reporting requirements. It empowers agencies to turn historical data, imagery, and documents into immediate operational intelligence.
While some companies are now announcing early-stage AI initiatives inspired by digital design tools, Dynamic Infrastructure has been implementing Engineering-AI™ in the field for years across thousands of assets. Its focus is on measurable results: extending asset lifetime, saving millions on day-to-day operations, and freeing engineers from time-consuming and repetitive analysis tasks, so they can focus on making critical decisions.
“AI for infrastructure is not about sketches or prototypes, it’s about understanding civil engineering reality and predicting what’s next,” added Dickman. “This release takes another major step toward our vision of giving every county and city “digital engineer” working for them, 24/7.”
About Dynamic Infrastructure Dynamic Infrastructure provides the world’s first Virtual Assistant Engineer, a cloud-based AI companion for civil engineers and asset managers that automates inspection analysis, deterioration forecasting, and maintenance justification. Trusted by agencies across the U.S., Europe, and Australia, the company’s Engineering-AI™ platform delivers actionable insights that keep infrastructure safe, resilient, and financially sustainable.
Company Marks Key Milestone in AI-Enhanced Cancer Diagnostics
HOUSTON, Nov. 11, 2025 — EXoPERT, a biotechnology company pioneering AI-powered exosome-based liquid biopsy diagnostics for multi-cancer early detection, is excited to announce that it has joined Johnson & Johnson’s global incubator network, JLABS, as a resident of JLABS TMC.
JLABS is the world’s largest network of open innovation ecosystems, empowering emerging life science companies with access to expertise, strategic partnerships, and venture connections across the pharmaceutical, biotechnology, and medical technology sectors.
“Joining this community of innovators marks an important milestone in EXoPERT’s journey to transform cancer diagnostics,” said Yeonho Choi, CEO of EXoPERT. “We aim to leverage its resources, infrastructure, and vibrant innovation ecosystem to help accelerate clinical validation and bring our AI-enhanced exosome technology closer to patients worldwide.”
EXoPERT is developing a multi-cancer early detection (MCED) platform that combines high-purity exosome isolation, surface-enhanced Raman spectroscopy (SERS)-based molecular pattern recognition, and advanced AI-driven analytics. By decoding the rich molecular signatures carried by extracellular vesicles, EXoPERT’s proprietary platform enables non-invasive, highly sensitive detection of early-stage cancers and has the potential to dramatically improve patient outcomes.
To advance clinical validation, EXoPERT is collaborating with leading U.S. institutions, including Johns Hopkins University School of Medicine, City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the US, and multiple Department of Veterans Affairs medical center sites nationwide. These next steps are crucial for evaluating the performance of EXoPERT’s diagnostic platform across diverse patient populations and accelerating its pathway toward regulatory approval.
About EXoPERT EXoPERT is a biotechnology company developing next-generation exosome-based liquid biopsy diagnostics for multi-cancer early detection and precision medicine applications. Its proprietary high-purity exosome isolation technology, combined with AI-enhanced analytics, provides unparalleled insights into tumor biology through a simple blood test. By enabling earlier diagnosis and more personalized treatment strategies, EXoPERT aims to make a meaningful impact on global cancer care. For more information, see exopert.com.
This is the second and final tranche of IBI Ag’s Series A Round for its novel bioinsecticide platform
NESS ZIONA, Israel, Nov. 11, 2025 — IBI Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, today announced the successful completion of its Series A funding round for a total of $10 million.
The investment was led by Corteva (“Corteva”) through its Corteva Catalyst platform, with the participation of The Trendlines Group (SGX:42T) (OTCQX: TRNLY), Iron Nation, Consensus Business Group (“CBG”), and a grant from the Israel Innovation Authority, joined by Bandera Capital and First Imagine Ventures, enabling the closing of the round.
The completion of this Series A represents a significant milestone for IBI Ag, underscoring growing global recognition of the company’s innovative antibody-based bioinsecticide platform. The funds will enable IBI Ag to accelerate product development and regulatory advancement of its next-generation biological pest control solutions.
IBI Ag’s proprietary technology leverages single-domain antibodies (nanobodies) to create highly effective, selective, and safe biological insect control products. Adapted from the pharmaceutical field and optimized for agriculture, this groundbreaking platform introduces new modes of action that protect high-value crops from both sucking and chewing insects, while minimizing environmental impact and preserving beneficial species.
“We’re proud to have the continued confidence of our investors and to welcome Bandera Capital and First Imagine Ventures to the IBI Ag family,” said Arnon Heyman, CEO of IBI Ag. “With the completion of our Series A, we are well positioned to bring our novel biological solutions closer to farmers worldwide, supporting both productivity and sustainability.”
“The collaboration between IBI Ag and Corteva is a clear example of how working together can deliver innovation that increases performance and provides more sustainable solutions in crop protection,” said Tom Greene, senior director at Corteva and global leader for Corteva Catalyst. “We are excited to continue exploring the development of next generation biologicals and naturally inspired solutions as IBI Ag advances toward commercialization.”
Corteva, through its Corteva Catalyst platform, collaborates with entrepreneurs and innovators to accelerate the development of early-stage, disruptive technologies that enable farmers to sustainably produce more food and feed.
About IBI Ag
IBI Ag is a pioneer in the Agri-biotech industry, developing innovative and sustainable crop protection solutions. The company’s proprietary nanobody technology provides a new mode of action for controlling a broad range of insect pests with minimal ecological footprint. Founded by The Trendlines Group together with Dr. Amir Ayali and Dr. Rony Oren Benaroya, and supported by the Israel Innovation Authority, IBI Ag is redefining the future of pest management.
The deep-tech fund is doubling down on dual-use innovation, setting the standard for how mission-focused venture scales.
BOSTON, Nov. 11, 2025 — J2 Ventures, the veteran-led venture firm investing where government purpose meets private innovation, today announced the close of its $250 million oversubscribed Brookhaven Fund counting JP Morgan, MetLife, Upsher Management, Alpha Leonis Partners and the State Investment Council of New Mexico as its LP’s, among other prominent institutions and family offices. One of the largest early-stage vehicles dedicated to dual-use technology, the new fund reflects the growing momentum behind J2’s approach and builds on the fund’s proven track record of strengthening both economic and national resilience by helping founders scale innovation with commercial reach and impact. What began as a focused strategy to bridge frontier technology and real-world impact has now become a proven playbook for scaling innovation that endures.
“There have been rocket-ship companies in every generation born out of early collaboration between national necessity and private ingenuity,” said Alex Harstrick, Managing Partner and Co-Founder of J2 Ventures. “Oracle began with a government project, Cisco and the early internet grew from federally funded research, and one of Pixar’s first customers came from the public sector. We’re entering a moment where urgency and investment are converging across both private venture and government to solve hard, consequential, and high-stakes problems. Brookhaven exists to accelerate that cycle, backing founders whose innovations strengthen not only national security but the everyday systems that keep society safer, healthier, and more connected.”
J2’s expertise lies in the collective experience of its team, which spans across national security, science, finance, entrepreneurship, and public policy. This cross-disciplinary perspective allows the firm to evaluate technologies through both mission-critical and market-driven lenses. Across its first two funds, J2 backed more than 35 companies advancing critical capabilities in health, infrastructure, and security.
Today, Government appetite for commercial innovation has accelerated as national priorities shift toward technological readiness, resilience, and deeper private-sector collaboration. Brookhaven will focus on early-stage investments in companies developing critical technologies across:
Advanced Computing
Cybersecurity
Communications Infrastructure
Artificial Intelligence
Healthcare, with an emphasis on remote physiological monitoring
“The most impactful innovation happens when founders are empowered with capital, insight, and access,” said Jonathan Bronson, PhD, Managing Partner and Co-Founder of J2 Ventures. “Our goal with Brookhaven is to ensure that world-changing technologies don’t get stuck on the lab bench, that they reach scale, adoption, and global impact, all while preserving value for the founder.”
Having helped pioneer the modern dual-use investment category, J2 combines commercial discipline with deep ties across defense and intelligence, helping founders secure non-dilutive capital and navigate complex regulatory environments and on average, J2-backed companies raise $2 in non-dilutive funding for every $1 the firm invests. Its portfolio includes:
Oura – Wearable technology reshaping personal health
Aalyria – Connectivity spin-out from Google delivering resilient global networks
Codemetal – AI translation for critical industries, now deployed across multiple Defense Programs
Apex Space – Mass-produced small satellites accelerating space infrastructure
The firm’s partnership remains anchored by Alex Harstrick and Jonathan Bronson, PhD, and includes General Partners Dr. Matt Goldman – former Chief Medical Officer of the Defense Innovation Unit and a retired Air Force Colonel, Christine Keung – former Chief Data Officer for the City of San Jose and political appointee at the Small Business Administration, and Master Chief (ret.) Adam Briley (Navy SEAL) – who leads J2’s Federal Programs initiatives. Together, they share a singular focus: helping founders transform emerging technologies into scalable solutions that advance both commercial and national interests.
J2 is also guided by some of the nation’s most respected military and business leaders: LTG (ret.) Patty Horoho, former Army Surgeon General and former CEO of UnitedHealthcare’s veteran business, Jennifer Cable, President of Thor Labs, one of the largest deep tech manufacturing companies in America, and Paul Gompers, the most published expert on Venture Capital at Harvard Business School, among others. They have all advised J2 since its founding, bringing deep expertise in healthcare innovation, operational readiness, and technology adoption across the public and private sectors.
Brookhaven is J2’s third consecutive oversubscribed fund, with virtually zero LP turnover, underscoring long-term confidence in both its performance and purpose.
About J2 Ventures
J2 Ventures is a Boston-based venture capital firm investing in technologies that advance both commercial markets and U.S. national security. Led by veterans, scientists, and entrepreneurs, the firm partners with early-stage companies developing critical innovations across advanced computing, cybersecurity, communications, and healthcare. J2 portfolio companies have raised more than $1 billion in follow-on capital and secured hundreds of millions in non-dilutive government funding, underscoring the firm’s mission to make innovation both scalable and enduring.
